首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1487495

骨科生物製品市场 - 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日期: 2024年04月04日 | 出版商:

Transparency Market Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

骨科生物製品市场 - 报告范围

TMR 关于全球骨科生物製品市场的报告研究了过去和当前的成长趋势以及机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。 -2031年，以2023年为基准年，2031年为预测年。该报告也提供了2023年至2031年全球骨科生物製品市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解骨科生物製品市场。

市场概况
2022年市场价值	62 亿美元
2031 年市场价值	103 亿美元
复合年增长率	5.7%

该报告深入研究了全球骨科生物製品市场的竞争格局。全球骨科生物製品市场的主要参与者已被确定，并且每位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球骨科生物製品市场参与者的属性。

简介与定义
主要发现/进展
2017-2031 年各产品市场价值预测
- 去矿骨基质 (DBM)
- 羟基磷灰石 (HAp)
- 透明质酸（HA）
- 硫酸钙基质
- B-磷酸三钙（B-TCP）
- B-TCP+HAp
- DBM+PLGA
- 再生医学
  - 富血小板血浆
  - BMAC
  - SVF
  - 其他（外泌体等）
- 生长因子
  - 骨形态发生蛋白2
  - 纤维母细胞生长因子2
  - 转化生长因子β
  - 血管内皮生长因子
  - 其他（IGF等）
按产品分類的市场吸引力

第 7 章：全球市场分析与预测：按最终用户

简介与定义
主要发现/进展
2017-2031 年最终用户市场价值预测
- 医院
- 骨科诊所
- 其他（耳鼻喉科诊所等）
最终用户的市场吸引力

第 8 章：全球市场分析与预测：按地区

主要发现
各地区市场价值预测
- 欧洲
- 印度
- 世界其他地区
按国家/地区分類的市场吸引力

第 9 章：欧洲市场分析与预测

德国
英国
法国
义大利
西班牙
欧洲其他地区

第 10 章：印度市场分析与预测

第 11 章：世界其他地区市场分析与预测

第 12 章：竞争格局

市场参与者 - 竞争矩阵（依公司层级和规模）
公司市占率分析 (2022)
公司简介
- Arthrex, Inc.
- ATEC Spine, Inc.
- Bioventus
- Exactech, Inc.
- Globus Medical
- Integra Lifesciences Corporation
- Johnson & Johnson
- Medtronic plc
- MTF Biologics
- NORAKER
- RTI Surgical
- Stryker
- Zimmer Biomet

简介目录图表

Product Code: TMRGL1747

Orthobiologics Market - Scope of Report

TMR's report on the global orthobiologics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global orthobiologics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global orthobiologics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the orthobiologics market.

Market Snapshot
Market Value in 2022	US$ 6.2 Bn
Market Value in 2031	US$ 10.3 Bn
CAGR	5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global orthobiologics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global orthobiologics market.

The report delves into the competitive landscape of the global orthobiologics market. Key players operating in the global orthobiologics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global orthobiologics market profiled in this report.

Key Questions Answered in Global orthobiologics Market Report:

What is the sales/revenue generated by orthobiologics across all regions during the forecast period?
What are the opportunities in the global orthobiologics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Orthobiologics Market - Research Objectives and Research Approach

The comprehensive report on the global orthobiologics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global orthobiologics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global orthobiologics market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Orthobiologics Market Analysis and Forecasts, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Technological Advancements in Orthobiologics
5.2. Incidence of Orthopedic Disorders
5.3. Regulatory Scenario, by Key Countries
5.4. Reimbursement Scenario, by Key Countries
5.5. Pricing Analysis of Orthobiologics
5.6. Pipeline Analysis
5.7. Overview of Most Effective Combinations of Orthobiologics products
5.8. COVID-19 Pandemic Impact Analysis

6. Global Orthobiologics Market Analysis and Forecasts, By Product

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2017-2031
- 6.3.1. Demineralized Bone Matrix (DBM)
- 6.3.2. Hydroxyapatite (HAp)
- 6.3.3. Hyaluronic acid (HA)
- 6.3.4. Calcium Sulfate Matrix
- 6.3.5. B-tricalcium phosphate (B-TCP)
- 6.3.6. B-TCP + HAp
- 6.3.7. DBM + PLGA
- 6.3.8. Regenerative Medicine
  - 6.3.8.1. PRP
  - 6.3.8.2. BMAC
  - 6.3.8.3. SVF
  - 6.3.8.4. Others (Exosome, etc.)
- 6.3.9. Growth Factors
  - 6.3.9.1. BMP2
  - 6.3.9.2. FGF2
  - 6.3.9.3. TGF beta
  - 6.3.9.4. VEGF
  - 6.3.9.5. Others (IGF, etc.)
6.4. Market Attractiveness By Product

7. Global Orthobiologics Market Analysis and Forecasts, By End-user

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2017-2031
- 7.3.1. Hospitals
- 7.3.2. Orthopedic Clinics
- 7.3.3. Others (ENT Clinics, etc.)
7.4. Market Attractiveness By End-user

8. Global Orthobiologics Market Analysis and Forecasts, By Region

8.1. Key Findings
8.2. Market Value Forecast By Region
- 8.2.1. Europe
- 8.2.2. India
- 8.2.3. Rest of the World
8.3. Market Attractiveness By Country/Region

9. Europe Orthobiologics Market Analysis and Forecast

9.1. Introduction
- 9.1.1. Key Findings
9.2. Market Value Forecast By Product, 2017-2031
- 9.2.1. Demineralized Bone Matrix (DBM)
- 9.2.2. Hydroxyapatite (HAp)
- 9.2.3. Hyaluronic acid (HA)
- 9.2.4. Calcium Sulfate Matrix
- 9.2.5. B-tricalcium phosphate (B-TCP)
- 9.2.6. B-TCP + Hap
- 9.2.7. DBM + PLGA
- 9.2.8. B-TCP + PLGA
- 9.2.9. Regenerative Medicine
  - 9.2.9.1. PRP
  - 9.2.9.2. BMAC
  - 9.2.9.3. SVF
  - 9.2.9.4. Others (Exosome, etc.)
- 9.2.10. Growth Factors
  - 9.2.10.1. BMP2
  - 9.2.10.2. FGF2
  - 9.2.10.3. TGF beta
  - 9.2.10.4. VEGF
  - 9.2.10.5. Others (IGF, etc.)
9.3. Market Value Forecast By End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Orthopedic Clinics
- 9.3.3. Others (ENT Clinics, etc.)
9.4. Market Value Forecast By Country, 2017-2031
- 9.4.1. Germany
- 9.4.2. U.K.
- 9.4.3. France
- 9.4.4. Italy
- 9.4.5. Spain
- 9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
- 9.5.1. By Product
- 9.5.2. By End-user
- 9.5.3. By Country

10. India Orthobiologics Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2017-2031
- 10.2.1. Demineralized Bone Matrix (DBM)
- 10.2.2. Hydroxyapatite (HAp)
- 10.2.3. Hyaluronic acid (HA)
- 10.2.4. Calcium Sulfate Matrix
- 10.2.5. B-tricalcium phosphate (B-TCP)
- 10.2.6. B-TCP + HAp
- 10.2.7. DBM + PLGA
- 10.2.8. B-TCP + PLGA
- 10.2.9. Regenerative Medicine
  - 10.2.9.1. PRP
  - 10.2.9.2. BMAC
  - 10.2.9.3. SVF
  - 10.2.9.4. Others (Exosome, etc.)
- 10.2.10. Growth Factors
  - 10.2.10.1. BMP2
  - 10.2.10.2. FGF2
  - 10.2.10.3. TGF beta
  - 10.2.10.4. VEGF
  - 10.2.10.5. Others (IGF, etc.)
10.3. Market Value Forecast By End-user, 2017-2031
- 10.3.1. Hospitals
- 10.3.2. Orthopedic Clinics
- 10.3.3. Others (ENT Clinics, etc.)
10.4. Market Attractiveness Analysis
- 10.4.1. By Product
- 10.4.2. By End-user

11. Rest of the World Orthobiologics Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2017-2031
- 11.2.1. Demineralized Bone Matrix (DBM)
- 11.2.2. Hydroxyapatite (HAp)
- 11.2.3. Hyaluronic acid (HA)
- 11.2.4. Calcium Sulfate Matrix
- 11.2.5. B-tricalcium phosphate (B-TCP)
- 11.2.6. B-TCP + HAp
- 11.2.7. DBM + PLGA
- 11.2.8. B-TCP + PLGA
- 11.2.9. Regenerative Medicine
  - 11.2.9.1. PRP
  - 11.2.9.2. BMAC
  - 11.2.9.3. SVF
  - 11.2.9.4. Others (Exosome, etc.)
- 11.2.10. Growth Factors
  - 11.2.10.1. BMP2
  - 11.2.10.2. FGF2
  - 11.2.10.3. TGF beta
  - 11.2.10.4. VEGF
  - 11.2.10.5. Others (IGF, etc.)
11.3. Market Value Forecast By End-user, 2017-2031
- 11.3.1. Hospitals
- 11.3.2. Orthopedic Clinics
- 11.3.3. Others (ENT Clinics, etc.)
11.4. Market Attractiveness Analysis
- 11.4.1. By Product
- 11.4.2. By End-user

12. Competition Landscape

12.1. Market Player - Competition Matrix (By Tier and Size of companies)
12.2. Market Share Analysis By Company (2022)
12.3. Company Profiles
- 12.3.1. Arthrex, Inc.
  - 12.3.1.1. Company Overview
  - 12.3.1.2. Financial Overview
  - 12.3.1.3. Product Portfolio
  - 12.3.1.4. Business Strategies
  - 12.3.1.5. Recent Developments
- 12.3.2. ATEC Spine, Inc.
  - 12.3.2.1. Company Overview
  - 12.3.2.2. Financial Overview
  - 12.3.2.3. Product Portfolio
  - 12.3.2.4. Business Strategies
  - 12.3.2.5. Recent Developments
- 12.3.3. Bioventus
  - 12.3.3.1. Company Overview
  - 12.3.3.2. Financial Overview
  - 12.3.3.3. Product Portfolio
  - 12.3.3.4. Business Strategies
  - 12.3.3.5. Recent Developments
- 12.3.4. Exactech, Inc.
  - 12.3.4.1. Company Overview
  - 12.3.4.2. Financial Overview
  - 12.3.4.3. Product Portfolio
  - 12.3.4.4. Business Strategies
  - 12.3.4.5. Recent Developments
- 12.3.5. Globus Medical
  - 12.3.5.1. Company Overview
  - 12.3.5.2. Financial Overview
  - 12.3.5.3. Product Portfolio
  - 12.3.5.4. Business Strategies
  - 12.3.5.5. Recent Developments
- 12.3.6. Integra Lifesciences Corporation
  - 12.3.6.1. Company Overview
  - 12.3.6.2. Financial Overview
  - 12.3.6.3. Product Portfolio
  - 12.3.6.4. Business Strategies
  - 12.3.6.5. Recent Developments
- 12.3.7. Johnson & Johnson
  - 12.3.7.1. Company Overview
  - 12.3.7.2. Financial Overview
  - 12.3.7.3. Product Portfolio
  - 12.3.7.4. Business Strategies
  - 12.3.7.5. Recent Developments
- 12.3.8. Medtronic plc
  - 12.3.8.1. Company Overview
  - 12.3.8.2. Financial Overview
  - 12.3.8.3. Product Portfolio
  - 12.3.8.4. Business Strategies
  - 12.3.8.5. Recent Developments
- 12.3.9. MTF Biologics
  - 12.3.9.1. Company Overview
  - 12.3.9.2. Financial Overview
  - 12.3.9.3. Product Portfolio
  - 12.3.9.4. Business Strategies
  - 12.3.9.5. Recent Developments
- 12.3.10. NORAKER
  - 12.3.10.1. Company Overview
  - 12.3.10.2. Financial Overview
  - 12.3.10.3. Product Portfolio
  - 12.3.10.4. Business Strategies
  - 12.3.10.5. Recent Developments
- 12.3.11. RTI Surgical
  - 12.3.11.1. Company Overview
  - 12.3.11.2. Financial Overview
  - 12.3.11.3. Product Portfolio
  - 12.3.11.4. Business Strategies
  - 12.3.11.5. Recent Developments
- 12.3.12. Stryker
  - 12.3.12.1. Company Overview
  - 12.3.12.2. Financial Overview
  - 12.3.12.3. Product Portfolio
  - 12.3.12.4. Business Strategies
  - 12.3.12.5. Recent Developments
- 12.3.13. Zimmer Biomet
  - 12.3.13.1. Company Overview
  - 12.3.13.2. Financial Overview
  - 12.3.13.3. Product Portfolio
  - 12.3.13.4. Business Strategies
  - 12.3.13.5. Recent Developments

简介目录图表

List of Tables

Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: India Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 07: India Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
Table 08: India Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
Table 09: India Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
Table 13: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
Table 14: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 15: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 16: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
Table 17: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
Table 18: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Orthobiologics Market Share Analysis, by Product, 2022
Figure 03: Global Orthobiologics Market Share Analysis, by End-user, 2022
Figure 04: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
Figure 05: Global Orthobiologics Market Share Analysis, by Product, 2022
Figure 06: Global Orthobiologics Market Share Analysis, by Product, 2031
Figure 07: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
Figure 08: Global Orthobiologics Market Revenue (US$ Mn), by Demineralized Bone Matrix (DBM), 2017-2031
Figure 09: Global Orthobiologics Market Value Share Analysis, by Demineralized Bone Matrix (DBM), 2022 and 2031
Figure 10: Global Orthobiologics Market Revenue (US$ Mn), by Hydroxyapatite (HAp), 2017-2031
Figure 11: Global Orthobiologics Market Value Share Analysis, by Hydroxyapatite (HAp), 2022 and 2031
Figure 12: Global Orthobiologics Market Revenue (US$ Mn), by Hyaluronic acid (HA), 2017-2031
Figure 13: Global Orthobiologics Market Value Share Analysis, by Hyaluronic acid (HA), 2022 and 2031
Figure 14: Global Orthobiologics Market Revenue (US$ Mn), by Calcium Sulfate Matrix, 2017-2031
Figure 15: Global Orthobiologics Market Value Share Analysis, by Calcium Sulfate Matrix, 2022 and 2031
Figure 16: Global Orthobiologics Market Revenue (US$ Mn), by B-tricalcium phosphate (B-TCP), 2017-2031
Figure 17: Global Orthobiologics Market Value Share Analysis, by B-tricalcium phosphate (B-TCP), 2022 and 2031
Figure 18: Global Orthobiologics Market Revenue (US$ Mn), by B-TCP + HAp, 2017-2031
Figure 19: Global Orthobiologics Market Value Share Analysis, by B-TCP + HAp, 2022 and 2031
Figure 20: Global Orthobiologics Market Revenue (US$ Mn), by DBM + HA, 2017-2031
Figure 21: Global Orthobiologics Market Value Share Analysis, by DBM + HA, 2022 and 2031
Figure 22: Global Orthobiologics Market Revenue (US$ Mn), by B-TCP + PLGA, 2017-2031
Figure 23: Global Orthobiologics Market Value Share Analysis, by B-TCP + PLGA, 2022 and 2031
Figure 24: Global Orthobiologics Market Revenue (US$ Mn), by Regenerative medicine, 2017-2031
Figure 25: Global Orthobiologics Market Value Share Analysis, by Regenerative medicine, 2022 and 2031
Figure 26: Global Orthobiologics Market Revenue (US$ Mn), by Growth Factors, 2017-2031
Figure 27: Global Orthobiologics Market Value Share Analysis, by Growth Factors, 2022 and 2031
Figure 28: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
Figure 29: Global Orthobiologics Market Share Analysis, by End-user, 2022
Figure 30: Global Orthobiologics Market Share Analysis, by End-user, 2031
Figure 31: Global Orthobiologics Market Revenue (US$ Mn), by Hospitals, 2017-2031
Figure 32: Global Orthobiologics Market Value Share Analysis, by Hospitals, 2022 and 2031
Figure 33: Global Orthobiologics Market Revenue (US$ Mn), by Orthopedic Clinics, 2017-2031
Figure 34: Global Orthobiologics Market Value Share Analysis, by Orthopedic Clinics, 2022 and 2031
Figure 35: Global Orthobiologics Market Revenue (US$ Mn), by Others, 2017-2031
Figure 36: Global Orthobiologics Market Value Share Analysis, by Others, 2022 and 2031
Figure 37: Global Orthobiologics Market Value Share Analysis, by Region, 2022 and 2031
Figure 38: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023-2031
Figure 39: India Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 40: India Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
Figure 41: India Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
Figure 42: India Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 43: India Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
Figure 44: Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 45: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 46: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 47: Europe Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
Figure 48: Europe Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
Figure 49: Europe Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 50: Europe Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
Figure 51: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 52: Rest of the World Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
Figure 53: Rest of the World Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
Figure 54: Rest of the World Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 55: Rest of the World Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
Figure 56: Market Share Analysis by Company (2022)